Why HCP Outreach is so Important For Recruiting Patients in Rare Disease
When it comes to recruiting patients for clinical trials in rare diseases, HCP outreach and support is essential. Most trials in the rare disease space struggle with patient recruitment unless they have a well thought out strategy on how to include HCPs in the recruitment process.
SubjectWell: This Patient Connection Platform Is Aiming To Transform A $2.4 Billion Market
SubjectWell Expands Executive Leadership to Realize Growth Strategy
AUSTIN, TX, April 6, 2023 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor […]
Compensation norms create inequity in clinical trials
Exploring how compensation practices in clinical trials contribute to inequities and hinder diverse patient participation
US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations
AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient […]
Secondary conditions and race/ethnicity affect type 2 diabetes patients’ interest in clinical trial participation.
SubjectWell recently fielded a survey engaging over 300 type 2 diabetes patients. The findings showed that diabetes patients demonstrated high overall interest in clinical trial participation, but secondary conditions caused by their diabetes can shift that interest higher or lower. According to the CDC, more than 33 million Americans have type 2 diabetes. As patients’ […]
Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase.
Clinical trial recruitment platform SubjectWell scores $35M
SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases
Read full article from Austin Inno
